Intravaginal CBD Hemp Extract for Endometriosis Symptom Relief
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for noncancerous gynecological disorders such as endometriosis, dysmenorrhea, and fibroids are inadequate, often providing only temporary relief and can have significant side effects or lead to infertility, with analgesics and invasive procedures being the primary options.
Innovation Solution
The use of intravaginal application of full spectrum hemp extract (FSHE) or broad spectrum hemp extract (BSHE) formulations containing cannabidiol (CBD) to treat these disorders, potentially combined with hormonal therapies, to target and destroy displaced endometrial cells and alleviate symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional treatments (analgesics, invasive procedures, hormone therapy) are used for endometriosis, then pain relief is achieved, but side effects increase and long-term relief is not provided
Solution Approach 1:
The patent changes the chemical parameter of the treatment by using CBD-rich hemp extract instead of traditional analgesics or hormone therapy. This parameter change provides long-term relief without the harmful side effects associated with conventional treatments, as CBD interacts with the endocannabinoid system to reduce inflammation and pain without the adverse effects of NSAIDs or opioids.
Solution Approach 2:
The patent extracts and isolates cannabidiol (CBD) from the cannabis plant to create a targeted therapeutic agent. By taking out the specific active compound CBD and formulating it in various delivery systems (topical creams, capsules, suppositories, tinctures), the treatment achieves reliable long-term pain relief while avoiding the side effects of non-selective traditional medications.
2Reliability
If invasive surgical procedures are used for endometriosis, then symptom relief is achieved, but fertility risk increases
Solution Approach 1:
The patent introduces CBD as an intermediary therapeutic agent that mediates between the need for symptom relief and the preservation of fertility. Instead of directly removing endometrial tissue through surgery, CBD-rich formulations target and reduce endometriotic lesions through anti-inflammatory and immunomodulatory mechanisms, providing symptom relief while preserving the reproductive system and fertility potential.
3Ease of operation
If monitoring the disease course is used for endometriosis, then no intervention is needed, but pain relief is not provided
Solution Approach 1:
The patent enables the patient's own endocannabinoid system to serve itself by introducing CBD, which acts as an exogenous ligand that activates cannabinoid receptors (CB1 and CB2) throughout the body. This self-service mechanism allows the body's natural pain modulation and anti-inflammatory systems to be enhanced, providing relief from endometriosis pain without requiring continuous medical intervention or surgery.
Data Source
AI summary
A method for treating a noncancerous gynecological disorder comprising: administering to a patient an effective amount of composition comprising a cannabis extract comprising cannabidiol (CBD) wherein the composition is preferably administered in a mucosal form, such as intravaginally.